Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin.
Jessica J P ShamiVincent Kc YanYue WeiHassan AlwafiJoseph E BlaisEric Yuk Fai WanCarlos King-Ho WongKa Shing CheungWai K LeungMartin Cs WongIan Ck WongEsther W ChanPublished in: Journal of internal medicine (2022)
Low-dose aspirin was not associated with a lower risk of CRC in patients with T2DM taking metformin. Our study does not support the routine use of low-dose aspirin in this population. This article is protected by copyright. All rights reserved.